Health Now
Live

Type 2 diabetes

Type 2 diabetes (T2D), formerly known as adult-onset diabetes, is a form of diabetes mellitus that is characterized by high blood sugar, insulin resistance, and relative lack of insulin. Common symptoms include increased thirst, frequent urination, fatigue and unexplained weight loss. Other symptoms include increased hunger, having a sensation of pins and needles, and sores (wounds) that heal slowly. Symptoms often develop slowly. Long-term complications from high blood sugar include heart disease; stroke; diabetic retinopathy, which can result in blindness; kidney failure; and poor blood flow in the lower limbs, which may lead to amputations. A sudden onset of hyperosmolar hyperglycemic state may occur; however, ketoacidosis is uncommon.

Read more on Wikipedia →

886trials recruiting now
United Statesmost trial sites (311)
400+mapped site locations
Novo Nordisk A/Smost active sponsor

Trials by phase

  • Early phase 113
  • Phase 157
  • Phase 264
  • Phase 376
  • Phase 472
  • Not applicable (device/behavioral)418
  • Observational study206

Phase 1 tests safety, phase 2 tests whether it works, phase 3 compares it with standard care, phase 4 follows it after approval.

Countries with the most trials

  • United States311
  • China124
  • Canada69
  • South Korea53
  • United Kingdom51
  • Germany49
  • Italy41
  • Spain40

Where trials are recruiting

Each dot is a site city; bigger dots have more recruiting trials. Showing up to 400 locations.

Lead sponsors

Novo Nordisk A/S · 16AstraZeneca · 15Eli Lilly and Company · 12The University of Texas Health Science Center at San Antonio · 9Seoul National University Bundang Hospital · 9Ohio State University · 7The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · 7Steno Diabetes Center Copenhagen · 7

Newest recruiting trials

See all 886 on ClinicalTrials.gov →

General information only, not medical advice. Trial listings are written by sponsors; eligibility and contacts are on each official listing.